TENET HEALTHCARE CORP (THC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 8B 16B 24B Q4 '17: 20.2B Q1 '18: 20.1B Q2 '18: 19.4B Q3 '18: 19B Q4 '18: 18.3B Q1 '19: 18.2B Q2 '19: 18.2B Q3 '19: 18.3B Q4 '19: 18.5B Q1 '20: 18.5B Q2 '20: 17.5B Q3 '20: 17.5B Q4 '20: 17.6B Q1 '21: 17.9B Q2 '21: 19.2B Q3 '21: 19.5B Q4 '21: 19.5B Q1 '22: 19.4B Q2 '22: 19.1B Q3 '22: 19B Q4 '22: 19.2B Q1 '23: 19.4B Q2 '23: 19.9B Q3 '23: 20.2B Q4 '23: 20.6B Q1 '24: 20.9B Q2 '24: 20.9B Q3 '24: 21B Q4 '24: 20.7B Q1 '25: 15.3B Q2 '25: 10.2B Q3 '25: 10.4B Q4 '25: 10.8B Q1 '26: 11.2B Q2 '26: 11.6B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 2.5B 5B 7.5B Q3 '16: 1.3B Q4 '16: 1.2B Q1 '17: 1.2B Q2 '17: 1.2B Q3 '17: 908M Q4 '17: 1.1B Q1 '18: 1.4B Q2 '18: 1.5B Q3 '18: 1.7B Q4 '18: 1.6B Q1 '19: 1.5B Q2 '19: 1.5B Q3 '19: 1.5B Q4 '19: 1.5B Q1 '20: 1.5B Q2 '20: 1.6B Q3 '20: 1.5B Q4 '20: 2B Q1 '21: 2.2B Q2 '21: 2.3B Q3 '21: 3B Q4 '21: 2.9B Q1 '22: 3B Q2 '22: 3B Q3 '22: 2.5B Q4 '22: 2.3B Q1 '23: 2.3B Q2 '23: 2.3B Q3 '23: 2.3B Q4 '23: 2.5B Q1 '24: 5.2B Q2 '24: 5.3B Q3 '24: 5.9B Q4 '24: 6B Q1 '25: 3.6B Q2 '25: 3.7B Q3 '25: 3.5B Q4 '25: 3.5B Q1 '26: 3.9B Q2 '26: 4.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-1.5B 0 1.5B 3B 4.5B Q3 '16: 155M Q4 '16: 176M Q1 '17: 178M Q2 '17: 171M Q3 '17: -198M Q4 '17: -320M Q1 '18: -165M Q2 '18: -89M Q3 '18: 265M Q4 '18: 466M Q1 '19: 347M Q2 '19: 360M Q3 '19: 149M Q4 '19: 171M Q1 '20: 258M Q2 '20: 306M Q3 '20: 346M Q4 '20: 768M Q1 '21: 831M Q2 '21: 919M Q3 '21: 1.6B Q4 '21: 1.5B Q1 '22: 1.5B Q2 '22: 1.5B Q3 '22: 1.1B Q4 '22: 1B Q1 '23: 1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.3B Q1 '24: 3.3B Q2 '24: 3.5B Q3 '24: 3.9B Q4 '24: 4.1B Q1 '25: 2.4B Q2 '25: 2.4B Q3 '25: 2.3B Q4 '25: 2.4B Q1 '26: 2.7B Q2 '26: 3.2B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 1.5B 3B 4.5B Q3 '14: 723M Q4 '14: 687M Q1 '15: 649M Q2 '15: 793M Q3 '15: 1.1B Q4 '15: 1B Q1 '16: 1.2B Q2 '16: 1.3B Q3 '16: 1B Q4 '17: 1.2B Q1 '18: 1.1B Q2 '18: 1.3B Q3 '18: 1.3B Q4 '18: 1B Q1 '19: 946M Q2 '19: 882M Q3 '19: 963M Q4 '19: 1.2B Q1 '20: 1.4B Q2 '20: 3.3B Q3 '20: 3.5B Q4 '20: 3.4B Q1 '21: 3.8B Q2 '21: 1.8B Q3 '21: 1.7B Q4 '21: 1.6B Q1 '22: 1.3B Q2 '22: 1.1B Q3 '22: 1B Q4 '22: 1.1B Q1 '23: 1.3B Q2 '23: 1.8B Q3 '23: 2B Q4 '23: 2.4B Q1 '24: 2.5B Q2 '24: 2.7B Q3 '24: 3.2B Q4 '25: 3.5B Q1 '26: 4.4B Q2 '26: 4B Q3 '15 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

Free Cash Flow TTM

-1.5B 0 1.5B 3B 4.5B Q3 '14: -304M Q4 '14: -246M Q1 '15: -187M Q2 '15: 24M Q3 '15: 289M Q4 '15: 184M Q1 '16: 364M Q2 '16: 359M Q3 '16: 152M Q4 '17: 493M Q1 '18: 475M Q2 '18: 633M Q3 '18: 671M Q4 '18: 432M Q1 '19: 280M Q2 '19: 197M Q3 '19: 258M Q4 '19: 563M Q1 '20: 692M Q2 '20: 2.7B Q3 '20: 2.9B Q4 '20: 2.9B Q1 '21: 3.3B Q2 '21: 1.3B Q3 '21: 1.1B Q4 '21: 910M Q1 '22: 570M Q2 '22: 414M Q3 '22: 243M Q4 '22: 321M Q1 '23: 462M Q2 '23: 961M Q3 '23: 1.1B Q4 '23: 1.6B Q1 '24: 1.8B Q2 '24: 1.9B Q3 '24: 2.4B Q4 '25: 2.5B Q1 '26: 3.3B Q2 '26: 3B Q3 '15 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '13: 103M Q3 '13: 103.1M Q1 '14: 97.2M Q2 '14: 97.7M Q3 '14: 100.9M Q1 '15: 100.9M Q2 '15: 99.2M Q3 '15: 99.5M Q1 '16: 98.8M Q2 '16: 99.3M Q3 '16: 99.5M Q1 '17: 100M Q2 '17: 100.6M Q3 '17: 100.8M Q1 '18: 102.7M Q2 '18: 104.2M Q3 '18: 102.4M Q1 '19: 102.8M Q2 '19: 104.6M Q3 '19: 103.6M Q1 '20: 105.7M Q2 '20: 105.6M Q3 '20: 105.3M Q1 '21: 108.1M Q2 '21: 108.6M Q3 '21: 108.8M Q1 '22: 112M Q2 '22: 108.8M Q3 '22: 109.9M Q1 '23: 106M Q2 '23: 104.8M Q3 '23: 104.4M Q1 '24: 100.6M Q2 '24: 98.4M Q3 '24: 96.7M Q1 '25: 95M Q2 '25: 91.8M Q3 '25: 88.6M Q1 '26: 87.6M Q2 '26: 84M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 0.00 15.00 30.00 45.00 Q3 '10: 1.94 Q4 '10: 8.16 Q1 '11: 8.13 Q2 '11: 8.19 Q3 '11: 6.56 Q4 '11: 0.48 Q1 '12: 0.87 Q2 '13: -0.53 Q3 '13: -0.63 Q4 '13: -1.32 Q1 '14: -0.80 Q2 '15: 0.58 Q3 '15: 0.20 Q4 '15: -1.41 Q1 '16: -2.48 Q2 '16: -2.33 Q3 '17: -5.51 Q4 '17: -6.99 Q1 '18: -5.50 Q2 '20: -0.50 Q3 '20: -0.18 Q4 '20: 3.71 Q1 '21: 3.73 Q2 '21: 4.00 Q3 '21: 9.99 Q4 '21: 8.42 Q1 '22: 8.80 Q2 '23: 4.60 Q3 '23: 4.38 Q4 '23: 5.71 Q1 '24: 25.77 Q2 '24: 27.26 Q3 '24: 31.21 Q4 '24: 32.34 Q1 '25: 15.23 Q2 '25: 15.73 Q3 '25: 14.70 Q4 '25: 15.48 Q1 '26: 19.22 Q2 '26: 25.92 Q3 '11 Q4 '13 Q1 '16 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.